Collection: "As Seen on TV" Viral Products
Discover the internet’s favorite finds in our Viral Products Collection! This curated selection brings you the quirky, fun, and must-have items making waves on TikTok, Instagram, and other social media platforms. Whether you’re shopping for yourself or looking for the perfect gift for that hard-to-please person, this is the ultimate collection for trending treasures and delightful oddities.
Please note: Products in the Viral Products Collection may ship from global locations and could take longer to arrive than standard products. But trust us—these unique, buzzworthy items are worth the wait! Bring the fun of "As Seen on TV" nostalgia to the modern age and surprise someone (or yourself) with a viral sensation today.
Plus, every purchase helps make a difference—profits from this collection go to Sky Foundation, a non-profit that funds pancreatic cancer research.

No products found
Use fewer filters or remove all
Latest News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...